Kidney/Renal Fibrosis Treatment-Global Market Status and Trend Report 2013-2023

Table of Contents

Chapter 1 Overview of Kidney/Renal Fibrosis Treatment

• 1.1 Definition of Kidney/Renal Fibrosis Treatment in This Report
• 1.2 Commercial Types of Kidney/Renal Fibrosis Treatment
  • 1.2.1 Angiotensin II Receptor Blockers (ARBs)
  • 1.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors
  • 1.2.3 Pirfenidone
  • 1.2.4 Renin Inhibitors
  • 1.2.5 Vasopeptidase Inhibitors
• 1.3 Downstream Application of Kidney/Renal Fibrosis Treatment
  • 1.3.1 Commercial/Private Hospitals
  • 1.3.2 Public Health Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Home Treatment
• 1.4 Development History of Kidney/Renal Fibrosis Treatment
• 1.5 Market Status and Trend of Kidney/Renal Fibrosis Treatment 2013-2023
  • 1.5.1 Global Kidney/Renal Fibrosis Treatment Market Status and Trend 2013-2023
  • 1.5.2 Regional Kidney/Renal Fibrosis Treatment Market Status and Trend 2013-2023

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Kidney/Renal Fibrosis Treatment 2013-2017
• 2.2 Production Market of Kidney/Renal Fibrosis Treatment by Regions
  • 2.2.1 Production Volume of Kidney/Renal Fibrosis Treatment by Regions
  • 2.2.2 Production Value of Kidney/Renal Fibrosis Treatment by Regions
• 2.3 Demand Market of Kidney/Renal Fibrosis Treatment by Regions
• 2.4 Production and Demand Status of Kidney/Renal Fibrosis Treatment by Regions
  • 2.4.1 Production and Demand Status of Kidney/Renal Fibrosis Treatment by Regions 2013-2017
  • 2.4.2 Import and Export Status of Kidney/Renal Fibrosis Treatment by Regions 2013-2017

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Kidney/Renal Fibrosis Treatment by Types
• 3.2 Production Value of Kidney/Renal Fibrosis Treatment by Types
• 3.3 Market Forecast of Kidney/Renal Fibrosis Treatment by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Kidney/Renal Fibrosis Treatment by Downstream Industry
• 4.2 Market Forecast of Kidney/Renal Fibrosis Treatment by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Kidney/Renal Fibrosis Treatment

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Kidney/Renal Fibrosis Treatment Downstream Industry Situation and Trend Overview

Chapter 6 Kidney/Renal Fibrosis Treatment Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Kidney/Renal Fibrosis Treatment by Major Manufacturers
• 6.2 Production Value of Kidney/Renal Fibrosis Treatment by Major Manufacturers
• 6.3 Basic Information of Kidney/Renal Fibrosis Treatment by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Kidney/Renal Fibrosis Treatment Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Kidney/Renal Fibrosis Treatment Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Kidney/Renal Fibrosis Treatment Major Manufacturers Introduction and Market Data

• 7.1 La Jolla Pharmaceutical Company
  • 7.1.1 Company profile
  • 7.1.2 Representative Kidney/Renal Fibrosis Treatment Product
  • 7.1.3 Kidney/Renal Fibrosis Treatment Sales, Revenue, Price and Gross Margin of La Jolla Pharmaceutical Company
• 7.2 Genzyme Corporation
  • 7.2.1 Company profile
  • 7.2.2 Representative Kidney/Renal Fibrosis Treatment Product
  • 7.2.3 Kidney/Renal Fibrosis Treatment Sales, Revenue, Price and Gross Margin of Genzyme Corporation
• 7.3 Pfizer Inc.
  • 7.3.1 Company profile
  • 7.3.2 Representative Kidney/Renal Fibrosis Treatment Product
  • 7.3.3 Kidney/Renal Fibrosis Treatment Sales, Revenue, Price and Gross Margin of Pfizer Inc.
• 7.4 Merck & Co.
  • 7.4.1 Company profile
  • 7.4.2 Representative Kidney/Renal Fibrosis Treatment Product
  • 7.4.3 Kidney/Renal Fibrosis Treatment Sales, Revenue, Price and Gross Margin of Merck & Co.
• 7.5 Galectin Therapeutics
  • 7.5.1 Company profile
  • 7.5.2 Representative Kidney/Renal Fibrosis Treatment Product
  • 7.5.3 Kidney/Renal Fibrosis Treatment Sales, Revenue, Price and Gross Margin of Galectin Therapeutics
• 7.6 F. Hoffman-La Roche Ltd.
  • 7.6.1 Company profile
  • 7.6.2 Representative Kidney/Renal Fibrosis Treatment Product
  • 7.6.3 Kidney/Renal Fibrosis Treatment Sales, Revenue, Price and Gross Margin of F. Hoffman-La Roche Ltd.
• 7.7 ProMetic Life-Sciences Inc.
  • 7.7.1 Company profile
  • 7.7.2 Representative Kidney/Renal Fibrosis Treatment Product
  • 7.7.3 Kidney/Renal Fibrosis Treatment Sales, Revenue, Price and Gross Margin of ProMetic Life-Sciences Inc.
• 7.8 InterMune Inc.
  • 7.8.1 Company profile
  • 7.8.2 Representative Kidney/Renal Fibrosis Treatment Product
  • 7.8.3 Kidney/Renal Fibrosis Treatment Sales, Revenue, Price and Gross Margin of InterMune Inc.
• 7.9 BioLine Rx Ltd
  • 7.9.1 Company profile
  • 7.9.2 Representative Kidney/Renal Fibrosis Treatment Product
  • 7.9.3 Kidney/Renal Fibrosis Treatment Sales, Revenue, Price and Gross Margin of BioLine Rx Ltd

Chapter 8 Upstream and Downstream Market Analysis of Kidney/Renal Fibrosis Treatment

• 8.1 Industry Chain of Kidney/Renal Fibrosis Treatment
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Kidney/Renal Fibrosis Treatment

• 9.1 Cost Structure Analysis of Kidney/Renal Fibrosis Treatment
• 9.2 Raw Materials Cost Analysis of Kidney/Renal Fibrosis Treatment
• 9.3 Labor Cost Analysis of Kidney/Renal Fibrosis Treatment
• 9.4 Manufacturing Expenses Analysis of Kidney/Renal Fibrosis Treatment

Chapter 10 Marketing Status Analysis of Kidney/Renal Fibrosis Treatment

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources